Physician profile
Raphaello Addiego
NPI 1841275427
$2,226.15
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $159 · 2021: $459 · 2022: $1,488.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $1,717.78 | 2021-2022 | |
| Novartis Pharmaceuticals Corporation | $138.95 | 2019-2020 | |
| Allergan, INC. | $115.64 | 2020-2021 | |
| Genentech USA, INC. | $68.80 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $67.26 | 2020-2022 | |
| Alcon Vision LLC | $40.98 | 2021 | |
| Optos, INC. | $35.71 | 2019 | |
| Abbvie INC. | $23.33 | 2022 | |
| New World Medical,INC. | $17.70 | 2021 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raphaello Addiego listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.